Standards for Ocular Toxicology and Inflammation (PDF)

Dr. Brian Gilger received his veterinary degree from The Ohio State University in Columbus, Ohio. After an ophthalmology residency and masters degree at Auburn University, Dr. Gilger returned to The Ohio State University as an Assistant Professor; then in October 1995, he joined the faculty at North Carolina State University where he is now a Professor and head of clinical ophthalmology. Dr. Gilger has been president of the American College of Veterinary Ophthalmologists, a board member of the Ocular Toxicology Sub-specialty (OTSS) of the Society of Toxicology, and a member of the AAALAC Board of Trustees. Dr. Gilger has been a member of the Association in Research in Vision and Ophthalmology (ARVO) since 1989 and served on the ARVO Animals in Research Committee for 8 years, including serving as chair of this committee for 3 years. He is a Silver Fellow of ARVO (2016). He is the co-founder and current President of the International Equine Ophthalmology Consortium. He is board certified in Veterinary Ophthalmology and Toxicology. Dr. Gilger's research is focused on sustained ocular drug delivery, ocular pharmacology, gene and cell therapy, animal models of ocular inflammation, and ocular immunology. He is a consultant for many pharmaceutical companies and CROs, has authored over 150 peer-reviewed scientific manuscripts, has written over 30 book chapters, and is the editor of six books, including 3 editions of Equine Ophthalmology, the 2014 Springer publication Ocular Pharmacology and Toxicology.

Dr. Cynthia Cook received the DVM degree from Iowa State University. She completed a residency in veterinary ophthalmology concurrent with a Master's Degree in Pharmacology and Toxicology at North Carolina State University, following by a PhD in Cell Biology and Anatomy at the University of North Carolina. Dr. Cook became board certified in veterinary ophthalmology in 1986 and has served as the President of the American College of Veterinary Ophthalmologists and on